$67 Million in First Closing of New Burrill VC Fund | GenomeWeb
Home » $67 Million in First Closing of New Burrill VC Fund

$67 Million in First Closing of New Burrill VC Fund

Oct 24, 2002

NEW YORK, Oct. 24-Burrill & Company today announced the closing of a new $67 million life sciences venture capital fund.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Aug 15, 2016

Qiagen Announces $250M Synthetic Share Repurchase Program

Sep 28, 2016

Western University Spins Out New Phosphoproteomics Firm Precision Proteomics

Premium
Oct 21, 2015

NeoGenomics to Acquire Clarient From GE

Nov 02, 2015

Illumina Launches $250M Share Repurchase Program

May 12, 2016

HTG Molecular Diagnostics Q1 Revenues Dip 14 Percent

Jun 24, 2016

CRISPR Therapeutics Raises $38M in Part of Series B Financing

The Scan

This Week in Science

In Science this week: global genetic diversity map, and more.

To Follow Up On

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

Look into the (Possible) Future

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Urged to Amend

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.

Sponsorships

Privacy Policy.  Copyright © 2016 Genomeweb LLC.  All Rights Reserved.